Saluron and Procedural nausea - a phase IV clinical study of FDA data
Summary:
We study 1,348 people who take Saluron (hydroflumethiazide) or have Procedural nausea. No report of Procedural nausea is found in people who take Saluron.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Saluron?
Saluron has active ingredients of hydroflumethiazide. eHealthMe is studying from 1 Saluron user. Check the latest studies of Saluron.
What is Procedural Nausea?
Procedural nausea is found to be associated with 137 drugs and 237 conditions by eHealthMe. Check the latest studies of Procedural nausea.
No report is found.
Do you take Saluron and have Procedural nausea?
- Check whether Procedural nausea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Saluron:
- Saluron (1 reports)
Procedural nausea treatments and more:
- Procedural nausea (1,347 reports)
How severe was Procedural nausea and when was it recovered:
Expand to all the drugs that have ingredients of hydroflumethiazide:
Browse all side effects of Saluron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Procedural nausea:
Browse all the conditions that are associated with Procedural nausea:
How the study uses the data?
The study uses data from the FDA. It is based on hydroflumethiazide (the active ingredients of Saluron) and Saluron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zofran cause Metastases To Abdominal Cavity? - 10 seconds ago
- Drug Withdrawal Syndrome and drugs of ingredients of buprenorphine hydrochloride; naloxone hydrochloride - 13 seconds ago
- Flexeril and Ards (Acute Respiratory Distress Syndrome) for Women aged 30-39 - 17 seconds ago
- Flexeril and Stiff Lung for Women aged 30-39 - 17 seconds ago
- Flexeril and Shock Lung for Women aged 30-39 - 18 seconds ago
- Flexeril and Non-Cardiogenic Pulmonary Edema for Women aged 30-39 - 18 seconds ago
- Flexeril and Increased-Permeability Pulmonary Edema for Women aged 30-39 - 18 seconds ago
- Flexeril and Adult Respiratory Distress Syndrome for Women aged 30-39 - 19 seconds ago
- Flexeril and Acute Lung Injury for Women aged 30-39 - 19 seconds ago
- Flexeril and Acute Respiratory Distress Syndrome for Women aged 30-39 - 19 seconds ago